Cancer cachexia: a nutritional or a systemic inflammatory syndrome?

被引：73
作者：
McGovern, Josh [1 ]
Dolan, Ross D. [1 ]
Skipworth, Richard J. [2 ]
Laird, Barry J. [2 ,3 ]
McMillan, Donald C. [1 ]
机构：
[1] Univ Glasgow, Glasgow Royal Infirm, Acad Unit Surg, Sch Med, Glasgow, Lanark, Scotland
[2] Univ Edinburgh, Inst Canc, Edinburgh, Midlothian, Scotland
[3] St Columbas Hosp, Edinburgh, Midlothian, Scotland
来源：
BRITISH JOURNAL OF CANCER | 2022年 / 127卷 / 03期
关键词：
PROGNOSTIC VALUE; CLINICAL-TRIALS; LUNG; MANAGEMENT; TUMOR;
D O I：
10.1038/s41416-022-01826-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Cancer cachexia has long been perceived as a nutritional syndrome. However, nutritional interventions have continued to be ineffective. With the recent recognition of the importance of systemic inflammation in the definition of this syndrome and treatment, has the time come to consider whether this syndrome is primarily a manifestation of systemic inflammation with the consequent implications for future treatment?
引用
收藏
页码：379 / 382
页数：4
相关论文
共 51 条
[1]   Comparison of the prognostic value of MUST, ECOG-PS, mGPS and CT derived body composition analysis in patients with advanced lung cancer [J].
Abbass, Tanvir ;
Dolan, Ross D. ;
MacLeod, Nicholas ;
Horgan, Paul G. ;
Laird, Barry J. ;
McMillan, Donald C. .
CLINICAL NUTRITION ESPEN, 2020, 40 :349-356
[2]   The Relationship between Imaging-Based Body Composition Analysis and the Systemic Inflammatory Response in Patients with Cancer: A Systematic Review [J].
Abbass, Tanvir ;
Dolan, Ross D. ;
Laird, Barry J. ;
McMillan, Donald C. .
CANCERS, 2019, 11 (09)
[3]   Interleukin-6 receptor blockade in patients with COVID-19: placing clinical trials into context [J].
Angriman, Federico ;
Ferreyro, Bruno L. ;
Burry, Lisa ;
Fan, Eddy ;
Ferguson, Niall D. ;
Husain, Shahid ;
Keshavjee, Shaf H. ;
Lupia, Enrico ;
Munshi, Laveena ;
Renzi, Samuele ;
Ubaldo, Onion Gerald, V ;
Rochwerg, Bram ;
Del Sorbo, Lorenzo .
LANCET RESPIRATORY MEDICINE, 2021, 9 (06) :655-664
[4]   ESPEN guidelines on enteral nutrition:: Non-surgical oncology [J].
Arends, J. ;
Bodoky, G. ;
Bozzetti, F. ;
Fearon, K. ;
Muscaritoli, M. ;
Selga, G. ;
van Bokhorst-de van der Schuereng, M. A. E. ;
von Meyenfeldt, M. ;
Zuercher, G. ;
Fietkau, R. ;
Aulbert, E. ;
Frick, B. ;
Holm, M. ;
Kneba, M. ;
Mestrom, H. J. ;
Zander, A. .
CLINICAL NUTRITION, 2006, 25 (02) :245-259
[5]   Cancer cachexia in adult patients: ESMO Clinical Practice Guidelines [J].
Arends, J. ;
Strasser, F. ;
Gonella, S. ;
Solheim, T. S. ;
Madeddu, C. ;
Ravasco, P. ;
Buonaccorso, L. ;
de van der Schueren, M. A. E. ;
Baldwin, C. ;
Chasen, M. ;
Ripamonti, C., I .
ESMO OPEN, 2021, 6 (03)
[6]   ESPEN expert group recommendations for action against cancer-related malnutrition [J].
Arends, J. ;
Baracos, V. ;
Bertz, H. ;
Bozzetti, F. ;
Calder, P. C. ;
Deutz, N. E. P. ;
Erickson, N. ;
Laviano, A. ;
Lisanti, M. P. ;
Lobo, D. N. ;
McMillan, D. C. ;
Muscaritoli, M. ;
Ockenga, J. ;
Pirlich, M. ;
Strasser, F. ;
de van der Schueren, M. ;
Van Gossum, A. ;
Vaupel, P. ;
Weimann, A. .
CLINICAL NUTRITION, 2017, 36 (05) :1187-1196
[7]   Cancer-associated cachexia [J].
Baracos, Vickie E. ;
Martin, Lisa ;
Korc, Murray ;
Guttridge, Denis C. ;
Fearon, Kenneth C. H. .
NATURE REVIEWS DISEASE PRIMERS, 2018, 4
[8]   New biomarkers for checkpoint inhibitor therapy [J].
Burdett, Nikki ;
Desai, Jayesh .
ESMO OPEN, 2020, 5
[9]   ESPEN guidelines on definitions and terminology of clinical nutrition [J].
Cederholm, T. ;
Barazzoni, R. ;
Austin, P. ;
Ballmer, P. ;
Biolo, G. ;
Bischoff, S. C. ;
Compher, C. ;
Correia, I. ;
Higashiguchi, T. ;
Hoist, M. ;
Jensen, G. L. ;
Malone, A. ;
Muscaritoli, M. ;
Nyulasi, I. ;
Pirlich, M. ;
Rothenberg, E. ;
Schindler, K. ;
Schneider, S. M. ;
de van der Schueren, M. A. E. ;
Sieber, C. ;
Valentini, L. i ;
Yu, J. C. ;
Van Gossum, A. ;
Singer, P. .
CLINICAL NUTRITION, 2017, 36 (01) :49-64
[10]  
Cederholm T, 2019, CLIN NUTR, V38, P1, DOI [10.1002/jcsm.12383, 10.1016/j.clnu.2019.02.033, 10.1016/j.clnu.2018.08.002, 10.1002/jpen.1440]
123456